Callum Munro Spreng
Chief Executive Officer at Spreng Thomson Ltd.
Network origin in Callum Munro Spreng first degree
Entity | Entity type | Industry | |
---|---|---|---|
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Spreng & Co. Ltd.
Spreng & Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Spreng & Co. Ltd. provides public relations services. Its services include media relations, PR campaigns, corporate communications, social media, stakeholder relations. media training, and crisis handling. The company was founded on February 13, 2008 and is headquartered in Glasgow, the United Kingdom.
4
| Subsidiary | Miscellaneous Commercial Services | 4 |
Spreng Thomson Ltd.
Spreng Thomson Ltd. Specialty TelecommunicationsCommunications Spreng Thomson Ltd. provides creative communications consulting services. It offers communications strategy, reputation management, facilitation, media relations, crisis communications, social and digital media strategy and support, media and social media training, and media and political monitoring and intelligence gathering services. The company was founded in 2016 and is headquartered in Glasgow, the United Kingdom.
2
| Private Company | Specialty Telecommunications | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Callum Munro Spreng via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Pharmaceuticals: Major | Director/Board Member | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Helsinn Healthcare SA
Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
SARTORIUS AG | Pharmaceuticals: Major | Director/Board Member | |
University of Bristol | College/University | Doctorate Degree | |
HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Chairman | |
Endocrine Pharmaceuticals Ltd.
Endocrine Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Endocrine Pharmaceuticals Ltd. engages in the development of hormonal drugs. If focuses on the research of micrin a naturally occurring mammalian hormonal inhibitor of tissue masses and cellular integrity. The company is headquartered in Tadley, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Coventry University | College/University | Undergraduate Degree | |
University of Surrey | College/University | Doctorate Degree | |
University of Pavia | College/University | Doctorate Degree | |
VERONA PHARMA PLC | Pharmaceuticals: Major | Chairman | |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Italfarmaco SpA
Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member | |
King's College London | College/University | Doctorate Degree | |
KYOWA KIRIN CO. LTD. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
OM Pharma SA
OM Pharma SA Pharmaceuticals: MajorHealth Technology OM Pharma SA engages in manufacture of pharmaceutical products. Its portfolio includes products for respiratory tract infections, lower urinary tract infections, chronic venous insufficiency, microangiopathies, hemorrhoids, and menometrorrhagia. The company was founded by Jean-Rene Ricard in 1937 and is headquartered in Meyrin, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
Quanta Dialysis Technologies Ltd.
Quanta Dialysis Technologies Ltd. Medical SpecialtiesHealth Technology Quanta Dialysis Technologies Ltd. develops haemodialysis systems. The firm's SC+ is a performance, portable, compact haemodialysis system providing clinical efficacy utilising flow rates typically used on traditional machines. It offers SelfCare+, a haemodialysis machine for dialysis patients to control their disease and determine the treatment regime and care. The company was founded by Clive Henrey Buckberry, John Eric Milad and Martin Johnson in 2008 and is headquartered in Alcester, the United Kingdom. | Medical Specialties | Director/Board Member | |
Helsinn Holding SA
Helsinn Holding SA Hospital/Nursing ManagementHealth Services Helsinn Holding SA is a holding Swiss company that provides cancer services through its subsidiaries. The private company is based in Lugano, Switzerland and has subsidiaries in Switzerland and Ireland. The company was founded in 1976 by Gabriele Edoardo Braglia. Riccardo Braglia has been the CEO of the company since 2002. | Hospital/Nursing Management | Director/Board Member | |
BSP Pharmaceuticals SpA
BSP Pharmaceuticals SpA Pharmaceuticals: MajorHealth Technology BSP Pharmaceuticals SpA develops and manufactures anticancer drugs. It offers development, clinical supply, commercial supply, and analytical services. The company was founded by Aldo Braca in July 2006 and is headquartered in Latina Scalo, Italy. | Pharmaceuticals: Major | Director/Board Member | |
Pfizer GmbH | Corporate Officer/Principal | ||
Warburg Pincus International LLC | Investment Managers | Private Equity Investor | |
Pharmacia & Upjohn SpA | Corporate Officer/Principal | ||
Prismic Pharmaceuticals, Inc.
Prismic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prismic Pharmaceuticals, Inc. engages in the research and development of prescription drugs for kidney disease, mental health, and chronic pain. It also offers medical foods for patients with chronic kidney disease, and depression and bipolar disorder. The company was founded by Zachary Dutton, Danilo Casadei Massari, and Peter J. Moriarty in 2011 and is headquartered in Worcester, MA. | Pharmaceuticals: Major | Director/Board Member | |
Soho Flordis International Pty Ltd.
Soho Flordis International Pty Ltd. Pharmaceuticals: OtherHealth Technology Soho Flordis International Pty Ltd. manufactures natural medicine products. Its brands include flordis, ProThera, COMPLEMENTARY, ginsana and KLAIRE LABS. Its products include ginsana, keenmind, nuvexa and gincosan. The company was founded in 2010 and is headquartered in St. Leonards, Australia. | Pharmaceuticals: Other | Director/Board Member | |
Cell Therapy Ltd.
Cell Therapy Ltd. BiotechnologyHealth Technology Cell Therapy Ltd. produces regenerative medicines using adult stem cells to treat heart failure. Its product HeartCel, a stem cell therapy that offers improved outcomes for heart failure patients by reducing the size of heart scar, improving heart function, quality of life and reducing mortality. The firm develops therapies based on the adult mesenchymal stromal cells technology platform. The firm’s regenerative therapies will focus on curing the cause of the disease, rather than only treating the symptoms. The company was founded in 2009 by Martin John Evans and Ajan Trevor Reginald and is headquartered in Cardiff, the United Kingdom. | Biotechnology | Director/Board Member | |
NIOX GROUP PLC | Medical/Nursing Services | Chairman | |
MEREO BIOPHARMA GROUP PLC | Biotechnology | Director/Board Member | |
Helsinn Healthcare SA /Venture/
Helsinn Healthcare SA /Venture/ Investment ManagersFinance 3B FUTURE HEALTH VENTURES SARL (3B Future Health Ventures) is a venture capital subsidiary of Helsinn Healthcare SA founded in 2016. The firm is headquartered in Monaco, Luxembourg. | Investment Managers | Private Equity Investor | |
FSI SGR SpA
FSI SGR SpA Investment ManagersFinance FSI SGR SpA (FSI) also known as Fondo Strategico Italiano, is an independent private equity firm. The firm was founded in 2016 and is headquartered in Milan, Italy. | Investment Managers | Private Equity Investor | |
Micromega Ltd.
Micromega Ltd. Miscellaneous Commercial ServicesCommercial Services Micromega Ltd. provides business support services. The private company is based in London, UK. The British company was founded by Francesco Granata. | Miscellaneous Commercial Services | Founder | |
UTILITY therapeutics Ltd.
UTILITY therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Utility Therapeutics Ltd. is a British company that has exclusive US commercial rights to two European-approved antibiotics, mecillinam and an oral prodrug of mecillinam, for the treatment of urinary tract infections (UTI). The private company is based in Altrincham, UK and was founded in 2018 by Rasmus Toft-Kehler, Morten Otto Alexander Sommer, Peter Aksel Villadsen. Mecillinam is being developed as a first-line therapy for complicated UTI in the hospital setting, while the oral prodrug is being developed for uncomplicated UTI. The company has received the FDA's Qualified Infectious Disease Product (QIDP) designation for the treatment of UTI. Utility Therapeutics is committed to developing antibiotics that meet urgent treatment needs for multi-drug resistant infections. | Pharmaceuticals: Generic | Director/Board Member | |
ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Diadem SpA
Diadem SpA Miscellaneous Commercial ServicesCommercial Services Diadem Srl predicts, monitors, diagnosis and drug development for Alzheimer?s disease. focuses on specific research on early peripheral markers of Alzheimer's disease into technology. The company was founded by Maurizio Memo and Daniela Uberti in June 2012 and is headquartered in Brescia, Italy. | Miscellaneous Commercial Services | Director/Board Member | |
ARECOR THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
United Kingdom | 19 |
United States | 11 |
Switzerland | 7 |
Italy | 7 |
Germany | 4 |
Sectoral
Health Technology | 33 |
Finance | 6 |
Consumer Services | 6 |
Commercial Services | 5 |
Health Services | 3 |
Operational
Director/Board Member | 40 |
Corporate Officer/Principal | 22 |
Chairman | 10 |
Chief Executive Officer | 9 |
Independent Dir/Board Member | 5 |
Most connected contacts
- Stock Market
- Insiders
- Callum Munro Spreng
- Company connections